In an online forum scheduled for June 27, 2017, the regenerative medicine social media network RegMedNet will sponsor a panel discussion on emerging developments in the global landscape of government regulations for stem cell medical research. Asymmetrex, a company developing new methods for specifically quantifying adult tissue stem cells, will provide expertise on the panel for the impact of a new emerging technology for determining the quality and dose of adult tissue stem cell treatments.
(PRWeb June 22, 2017)
Read the full story at http://www.prweb.com/releases/2017/06/prweb14449131.htm
For more information, please visit
http://www.prweb.com/releases/2017/06/prweb14449131.htm